নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm healthcare a/s - klorheksidindihydroklorid / lidokainhydrokloridmonohydrat - sugetablett, komprimert med mentolsmak - 5 mg / 1 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm healthcare a/s - klorheksidindihydroklorid / lidokainhydrokloridmonohydrat - sugetablett, komprimert med sitronsmak - 5 mg / 1 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

macure pharma aps - petidinhydroklorid - injeksjonsvæske, oppløsning - 50 mg/ ml

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

eurocept international b.v - cefalotinnatrium - pulver til infusjonsvæske, oppløsning - 2 g

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

eurocept international b.v - cefalotinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

nordic group b.v. - methotrexate - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

viatris healthcare limited - tobramycin - cystic fibrosis; respiratory tract infections - antibakterielle midler for systemisk bruk, - tobi podhaler er angitt for undertrykkende behandling av kroniske lunge infeksjoner forårsaket av pseudomonas aeruginosa i voksne og barn i alderen 6 år og eldre med cystisk fibrose. se avsnitt 4. 4 og 5. 1 om data i ulike aldersgrupper. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

pari pharma gmbh - tobramycin - cystic fibrosis; respiratory tract infections - antibakterielle midler for systemisk bruk , aminoglycoside antibakterielle midler - vantobra er indisert for behandling av kronisk lunginfeksjon på grunn av pseudomonas aeruginosa hos pasienter i alderen 6 år og eldre med cystisk fibrose (cf). det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

bristol-myers squibb ab - aztreonam - pulver til injeksjons-/infusjonsvæske, oppløsning - 2 g